吡哆胺

吡哆胺
	IUPAC名めい; 4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol
识别
CAS号ごう	85-87-0
PubChem	1052
ChemSpider	1023
SMILES	Oc1c(c(cnc1C)CO)CN;
InChI	1/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3;
InChIKey	NHZMQXZHNVQTQA-UHFFFAOYAS
ChEBI	16410
KEGG	C00534
性せい质
化学かがく式しき	C8H12N2O2
摩ま尔质量りょう	168.19 g·mol−1
	若わか非ひ注ちゅう明あかり，所有しょゆう数すう据すえ均ひとし出自しゅつじ标准状じょう态（25 ℃，100 kPa）下した。

吡哆胺（英語えいご：Pyridoxamine），分子ぶんし式しきC₈H₁₂N₂O₂，是ぜ一种被称为维生素もとB₆的てき化合かごう物ぶつ之の一いち，另外两个分ぶん别是：吡哆醛与あずか吡哆醇あつし，它与吡哆醇あつし的てき不同ふどう在ざい于4位い取と代だい基もと为氨甲きのえ基はじめ而非羟甲基もと^[1]。

参考さんこう文献ぶんけん[编辑]

^ Adrover M, Vilanova B, Frau J, Muñoz F, Donoso J. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect. Bioorg. Med. Chem. May 2008, 16 (10): 5557–69. PMID 18434162. doi:10.1016/j.bmc.2008.04.002.

外部がいぶ链接[编辑]

Clinical trials testing Pyridoxamine (clinicaltrials.gov):
- Effect of Pyridorin in Patients With Diabetic Nephropathy （页面存そん档备份，存そん于互联网档案あん馆） (NCT00320060)
- Effect of Pyridorin in Patients With Diabetic Nephropathy （页面存そん档备份，存そん于互联网档案あん馆） (NCT00320021)
- Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes （页面存そん档备份，存そん于互联网档案あん馆） (NCT00734253)

[Adrover_et_al-1] Adrover M, Vilanova B, Frau J, Muñoz F, Donoso J. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect. Bioorg. Med. Chem. May 2008, 16 (10): 5557–69. PMID 18434162. doi:10.1016/j.bmc.2008.04.002.

[1]